Elite in Immune Thrombocytopenic Purpura (ITP)

Renchi C. Yang

Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Tianjin, CN 
Elite in Immune Thrombocytopenic Purpura (ITP)
Chinese Academy Of Medical Sciences And Peking Union Medical College, 
Tianjin, CN 
OverviewLocationsClinical Research

Overview

Renchi Yang practices in Tianjin, China. Yang is rated as an Elite expert by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Their top areas of expertise are Blood Clots, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Thrombocytopenia, and Splenectomy.

Their clinical research consists of co-authoring 220 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 71 articles in the study of Immune Thrombocytopenic Purpura (ITP).

Locations

Chinese Academy Of Medical Sciences And Peking Union Medical College, Tianjin, 300020, China
Other Locations
State Key Laboratory Of Experimental Hematology, Tianjin Key Laboratory Of Gene Therapy For Blood Diseases, CAMS Key Laboratory Of Gene Therapy For Blood Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020, Tianjin 301600, Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100730, China
Hangzhou, 310006, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, 288 Nanjing Road, Xiaobailou, 300020, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

220 Total Publications

Clinical efficacy and safety of Octocog alfa in Chinese patients with hemophilia A: One-year follow-up results from the Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study
Clinical efficacy and safety of Octocog alfa in Chinese patients with hemophilia A: One-year follow-up results from the Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 7 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile